2022
A US-Wide Red Blood Cell Alloantibody Exchange Can Decrease Mortality and Produce Cost Savings in the Care of Alloimmunized Patients with Sickle Cell Disease
Goshua G, Hauser R, Tormey C, Pandya A, Hendrickson J. A US-Wide Red Blood Cell Alloantibody Exchange Can Decrease Mortality and Produce Cost Savings in the Care of Alloimmunized Patients with Sickle Cell Disease. Blood 2022, 140: 2147-2148. DOI: 10.1182/blood-2022-169099.Peer-Reviewed Original Research
2013
Chapter 64 Transfusion-Related Acute Lung Injury
Hendrickson J, Hillyer C. Chapter 64 Transfusion-Related Acute Lung Injury. 2013, 417-420. DOI: 10.1016/b978-0-12-397164-7.00064-1.Peer-Reviewed Original ResearchTransfusion-related acute lung injuryTRALI mitigation strategiesAcute lung injuryLung injuryConsensus panel criteriaTransfusion-related mortalityNoncardiogenic pulmonary edemaPulmonary edemaClinical syndromeAcute hypoxiaBlood productsPanel criteriaTransfusionInjuryFDALaboratory testsHypotensionEdemaFeverSyndromeMortalityIncidenceDiagnosisHypoxia